desde Redalyc
{{t.menu.searcher}}
{{t.menu.map}}
{{t.menu.cloud}}
{{t.menu.issue}}
{{t.formats.viewer}}
PDF [ 
HTML
{{t.formats.mobile}}
ePUB
XML JATS
Murad Alam, Michael Voight, Farrokh Habibzadeh, Chris Zielinski, Margaret A. Winker, Rakesh Aggarwal, Lorraine E. Ferris, Markus Heinemann, Jose Florencio Lapeña Jr, Sanjay A. Pai, Edsel Ing, Leslie Citrome.
Abstract: This statement revises our earlier “WAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications” (January 20, 2023). The revision reflects the proliferation of chatbots and their expanding use in scholarly publishing over the last few m
en es
Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palacio, Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina.
Abstract: Background Among the chronic myeloproliferative neoplasms (MPNs) not associated with BCR-ABL mutations are polycythemia vera, primary myelofibrosis, and essential thrombocythemia. These diseases are caused by mutations in genes, such as the JAK2, MPL, and CA
en es
Survival of patients living with HIV and cancer in Cali, Colombia
Fernando Rosso, Luis Gabriel Parra-Lara, Juan Pablo Arango-Ibañez, Juan J. Martínez-Arboleda, Juan C. Bravo, Ángela R. Zambrano, Paola Collazos, Francisco Andino, Angélica Badillo, Sebastián Estrada.
Abstract: Background People living with HIV have an increased risk of cancer compared to the general population. However, with the increase in life expectancy and advances in antiretroviral therapy, the survival of patients with cancer and HIV has changed.Objective To
en es
Ricardo Kenji Nawa, Marcio Luiz Ferreira De Camillis, Monique Buttignol, Fernanda Machado Kutchak, Eder Chaves Pacheco, Louise Helena Rodrigues Gonçalves, Leonardo Miguel Correa Garcia, Karina Tavares Timenetsky, Luiz Alberto Forgiarini Junior.
Abstract: Background The use of instruments in clinical practice with measurement properties tested is highly recommended, in order to provide adequate assessment and measurement of outcomes.Objective To calculate the minimum clinically important difference (MCID) an
en es
Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis
Jorge Andrés Lacouture Fierro, Daniel Andrés Ribero Vargas, Juanita Sánchez Cano, Lina Maria Gaviria Jaramillo, Oliver Gerardo Perilla Suarez, Kenny Mauricio Galvez Cárdenas, Sigifredo Ospina Ospina.
Abstract: Background Amyloid light chain (AL) amyloidosis is characterized by amyloid fibril deposition derived from monoclonal immunoglobulin light chains, resulting in multiorgan dysfunction. Limited data exist on the clinical features of AL amyloidosis. Objective
en es
|
|
||
|---|---|---|
|
|
||
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} |  |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|